Education
About Us
Working with TipRanks
Follow Us
National Health Investors (NHI)
NYSE:NHI
Top Page
National Health Investors
(NYSE:NHI)
77Outperform
Positive Factors
Earnings Growth
NHI is well-placed to drive above-peer earnings growth given its attractively priced capital.
Financial Performance
4Q24 FAD showed a 5.0% year-over-year increase, surpassing expectations with solid SHOP performance.
Growth Prospects
NHI's pipeline was expanded and reloaded, showing growth potential.
Negative Factors
Credit Exposure
NHI does have a $3.6m reserve against a mezz loan to SLM, which drove the CFFO cut.
Financial Impact
NHI will not receive any rent from SLM in 4Q and will also incur marginally higher legal/transition costs.
Occupancy Issues
Bickford's occupancy experienced a modest deterioration.
National Health Investors (NHI) vs. S&P 500 (SPY)
Market Cap
$3.41B
Dividend Yield4.82%
Average Volume (3M)254.06K
Price to Earnings (P/E)23.9
Beta (1Y)0.57
Revenue Growth4.88%
EPS Growth0.41%
CountryUS
Employees30
SectorReal Estate
Sector Strength69
IndustryREIT - Healthcare Facilities
Share Statistics
EPS (TTM)3.12
Shares Outstanding45,687,943
10 Day Avg. Volume253,692
30 Day Avg. Volume254,062
Financial Highlights & Ratios
PEG Ratio58.80
Price to Book (P/B)N/A
Price to Sales (P/S)10.00
Price to Cash Flow (P/CF)14.60
P/FCF Ratio35.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$78.40Price Target Upside4.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
National Health Investors Business Overview & Revenue Model
Company DescriptionIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
How the Company Makes MoneyNHI generates revenue primarily through lease agreements with healthcare operators who manage the properties in its portfolio. These leases are typically structured as triple-net leases, where the tenant is responsible for property taxes, insurance, and maintenance costs, providing a stable and predictable cash flow for NHI. The company's income is primarily derived from rental income paid by its tenants, which include senior living communities, skilled nursing facilities, and medical office buildings. Additionally, NHI may earn income from mortgage interest and fees associated with the financing of healthcare facilities. Strategic partnerships with reputable operators and a focus on high-demand healthcare sectors contribute significantly to its profitability.
National Health Investors Financial Statement Overview
Summary
National Health Investors demonstrates solid financial health with strong profitability margins and a stable balance sheet. The reduction in debt and strong cash flow management are positive indicators, though declining revenues pose a challenge. Overall, the company maintains a robust financial position, suitable for sustaining operations and strategic investments.Income Statement
The company's gross profit margin remains robust with a consistent EBIT margin reflecting efficient operations. However, there is a noticeable decline in total revenue from the previous year, impacting the revenue growth rate negatively. The net profit margin is strong, indicating efficient cost management.75
Positive
Balance Sheet
The balance sheet highlights a healthy equity ratio, signifying strong financial stability. With zero debt in the most recent period, the company has significantly reduced its leverage, improving its debt-to-equity ratio. Return on equity remains satisfactory, showcasing solid shareholder returns.82
Very Positive
Cash Flow
The operating cash flow to net income ratio is impressive, indicating strong cash-generating ability relative to profits. Free cash flow remains positive, ensuring liquidity. However, fluctuations in free cash flow growth suggest variability in cash management strategies.80
Positive
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 277.19M | 257.05M | 319.83M | 278.19M | 298.71M | 332.81M | Gross Profit |
| 265.52M | 257.05M | 308.32M | 268.41M | 287.08M | 323.16M | EBIT |
| 95.29M | 214.80M | 178.79M | 81.11M | 132.19M | 220.80M | EBITDA |
| 162.26M | 264.16M | 259.94M | 151.99M | 212.99M | 303.95M | Net Income Common Stockholders |
| 50.85M | 137.87M | 135.65M | 23.06M | 62.19M | 135.37M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 26.03M | 24.29M | 22.35M | 19.29M | 37.41M | 43.34M | Total Assets |
| 497.88M | 2.61B | 2.49B | 2.51B | 2.84B | 3.12B | Total Debt |
| 37.94M | 1.15B | 1.14B | 1.15B | 1.25B | 1.51B | Net Debt |
| 33.57M | 1.12B | 1.11B | 1.13B | 1.21B | 1.47B | Total Liabilities |
| 61.05M | 1.23B | 1.21B | 1.22B | 1.32B | 1.60B | Stockholders Equity |
| 436.82M | 1.37B | 1.25B | 1.27B | 1.51B | 1.51B |
| Cash Flow | Free Cash Flow | ||||
| 188.48M | 207.77M | 180.71M | 180.71M | 210.79M | 218.29M | Operating Cash Flow |
| 192.34M | 207.77M | 184.45M | 185.34M | 210.86M | 232.15M | Investing Cash Flow |
| 269.06M | -192.31M | -11.63M | 197.94M | 185.28M | -89.71M | Financing Cash Flow |
| -479.88M | -13.57M | -169.72M | -401.25M | -402.99M | -111.76M |
National Health Investors Technical Analysis
Positive
74.70
Price Trends
70.98
Positive
71.87
Positive
73.08
Positive
Market Momentum
0.98
Positive
57.77
Neutral
29.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHI, the sentiment is Positive. The current price of 74.7 is above the 20-day moving average (MA) of 73.98, above the 50-day MA of 70.98, and above the 200-day MA of 73.08, indicating a bullish trend. The MACD of 0.98 indicates Positive momentum. The RSI at 57.77 is Neutral, neither overbought nor oversold. The STOCH value of 29.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NHI.
National Health Investors Risk Analysis
National Health Investors disclosed 42 risk factors in its most recent earnings report. National Health Investors reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
National Health Investors Peers Comparison
Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $98.39B | 186.12 | 3.32% | 1.71% | 20.40% | 57.80% | |
77 Outperform | $3.41B | 23.90 | 10.53% | 4.82% | 4.88% | 0.41% | |
74 Outperform | $10.73B | 25.35 | 10.02% | 7.04% | 9.90% | 56.41% | |
70 Outperform | $7.11B | ― | -9.98% | ― | 16.29% | 43.84% | |
63 Neutral | $4.17B | 32.68 | 4.57% | 6.84% | 7.22% | 809.92% | |
63 Neutral | $30.88B | 352.80 | 0.80% | 2.62% | 9.48% | ― | |
61 Neutral | $4.71B | 17.72 | -2.95% | 11.43% | 6.02% | -21.34% |
* Real Estate Sector Average
Performance Comparison
NHI
National Health Investors
74.70
15.21
25.57%
WELL
Welltower
153.42
63.37
70.37%
OHI
Omega Healthcare
38.08
8.52
28.82%
SBRA
Sabra Healthcare REIT
17.54
3.88
28.40%
VTR
Ventas
68.76
26.90
64.26%
HCP
HashiCorp
34.78
8.97
34.75%
National Health Investors Earnings Call Summary
Earnings Call Date: Feb 25, 2025 | % Change Since: 4.78% | Next Earnings Date: May 12, 2025
Earnings Call Sentiment Positive
The earnings call presented a generally positive outlook with significant growth in key financial metrics and a strong investment pipeline. However, challenges in specific property performances and anticipated lower deferred rent collections were notable concerns.Highlights
Strong Cash Rent and NOI Growth
Cash rent increased by nearly 9% year over year, and NOI grew by 12.5% due to improved occupancy and margin improvement.
Significant Investments and Decreased Leverage
Investments of over $150 million were announced at an initial yield of 8.5%, and balance sheet leverage decreased to 4.1 times from 4.4 times in Q3.
Record Growth in Annual Metrics
Growth achieved in annual NAREIT FFO, normalized FFO, and FAD for the first time since 2020, exceeding the high end of original guidance.
Successful Capital Allocation
Over $235 million was announced at an average yield of 8.6%, marking the most active year since 2019.
High Confidence in Investment Pipeline
Closed a $21.2 million sale-leaseback in January, with $152.3 million under signed LOIs, and an active pipeline of approximately $190 million.
Positive Outlook for 2025
Guidance includes $225 million of incremental investments and expectations for 12% to 15% NOI growth in 2025.
Lowlights
Underperformance of Discovery Senior Living Properties
The properties did not perform as expected, with potential need to transition to another operator.
Deferred Rent Collection Concerns
2025 guidance includes only $4 million in deferred rent collection, down from $11 million in 2024, due to fewer extraordinary collections expected.
Interest Rate Environment Challenges
The interest rate environment has increased the cost of capital, affecting the ability to capitalize on investment opportunities.
Company Guidance
During the National Health Investors fourth quarter 2024 earnings call, Eric Mendelsohn, CEO, highlighted several key metrics that showcased the company's strong performance. The fourth quarter saw a nearly 9% year-over-year increase in cash rent, contributing to a 12.5% growth in net operating income (NOI). Investments exceeding $150 million were announced, yielding an initial return of 8.5%, and the company's leverage ratio decreased to 4.1 times from 4.4 times in the prior quarter. For the full year 2024, Bickford's cash rental income grew by approximately 17%, and shop NOI increased by about 32%, surpassing the high end of their guidance. Looking forward to 2025, the company anticipates 12% to 15% NOI growth, supported by an expected $225 million in incremental investments at an average yield of 8.1%. Furthermore, National Health Investors plans to strategically increase revenue per available room (RevPAR) while maintaining a robust balance sheet, positioning the company for continued growth.National Health Investors Corporate Events
Financial Disclosures
National Health Investors Releases Q4 2024 Financial Update
Neutral
Feb 25, 2025
National Health Investors has released its Supplemental Information for the quarter ended December 31, 2024. This release provides stakeholders with updated financial data and insights into the company’s performance during the specified period, which may impact its operational strategies and market positioning.
Business Operations and Strategy
National Health Investors Issues Strategic Investor Update
Neutral
Feb 25, 2025
On February 25, 2025, National Health Investors, Inc. issued an investor update available on their website. This update highlights the company’s strategic focus on maintaining its real estate investment trust status and addressing various operational risks, including those related to tenant financial health, regulatory changes, and environmental factors. The announcement underscores the company’s commitment to navigating potential challenges in the senior housing and medical investment sectors, emphasizing the importance of strategic management and risk mitigation for future growth.
Executive/Board Changes
National Health Investors Announces Board Member Resignation
Neutral
Feb 10, 2025
On February 7, 2025, National Health Investors, Inc. announced the resignation of Robert Webb from its Board of Directors, effective immediately. Webb, who has been a part of the board since its inception in 1991, played a pivotal role in the company’s growth to over $3.0 billion in investments across various healthcare real estate properties. His departure marks the end of a significant era of leadership for NHI, and the company acknowledges his invaluable contributions to its development.
Executive/Board ChangesBusiness Operations and Strategy
National Health Investors Revamps Board for Transparency
Positive
Jan 8, 2025
National Health Investors announced several changes to its Board of Directors to enhance strategic and independent guidance, including the appointment of Robert A. McCabe, Jr. as Chair and Candice W. Todd as a new board member. Additionally, the Board committed to measures promoting accountability and transparency, such as amending the Articles of Incorporation to remove the classified board structure and creating a management ESG Committee. These changes aim to strengthen governance and align with stakeholder feedback, reflecting an effort to bolster the company’s market position and operational transparency.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.